Annals of Oncology10.1093/annonc/mdw371.35201627vi218A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinomaS.H. Lim, Y.-L. Choi, S.-H. Jung, M.-J.A. Ahn, K. Park, J.I. Zo, Y.M. Shim, J.-M. Sun,,
Cancer Research and Treatment10.4143/crt.2016.4172017493816-823A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell CarcinomaSung Hee Lim, Young Mog Shim, Se Hoon Park, Hong Kwan Kim, Young Soo Choi, Myung-Ju Ahn, Keunchil Park, Jae Ill Zo, Jong-Mu Sun,,
Annals of Oncology10.1093/annonc/mdt203.57201324iv53Interim Safety Results From a Randomized Trial of Adjuvant Chemotherapy with Lv5Fu2 Vs. Folfox for Esophageal Squamous Cell CarcinomaSe Hoon Park, Jeeyun Lee, Yong Soo Choi, Jae Zo, Young Mok Shim,,
Yearbook of Oncology10.1016/s1040-1741(08)70092-720062006128Oxaliplatin Plus High-Dose Leucovorin and 5-Fluorouracil (FOLFOX 4) in Platinum-Resistant and Taxane-Pretreated Ovarian Cancer: A Phase II StudyJ.T. Thigpen,
Case Reports in Oncology10.1159/0004997052019121304-310Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard TherapiesSeiichiro Mitani, Shigenori Kadowaki, Kyoko Kato, Toshiki Masuishi, Kei Muro,
Trials10.1186/s13063-019-3349-92019201All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trialJie Shi, Juxian Sun, Chang Liu, Zongtao Chai, Nanya Wang, Hui Zhang, Shuqun Cheng,,
Annals of Oncology10.1093/annonc/mdh401200415101576-1577Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patientsC. Alliot,,
Cancer Chemotherapy and Pharmacology10.1007/s00280-013-2081-52013714905-911A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagusJialei Wang, Jianhua Chang, Hui Yu, Xianghua Wu, Huijie Wang, Wenhua Li, Dongmei Ji, Wei Peng,,
Oncology10.1159/000066518200264125-27A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell CarcinomaJ. Bennouna, R. Delva, F. Gomez, T. Lesimple, L. Geoffrois, C. Linassier, C. Chevreau, J.Y. Douillard, S. Négrier,
European Journal of Cancer Supplements10.1016/s1359-6349(09)71288-1200972380-3816567 Preoperative radiochemotherapy with cisplatin plus infusional high-dose 5-fluorouracil/leucovorin (LV5FU2) in locally-advanced esophageal carcinoma of UICC stages II and III – ongoing studyV. Stankovic, L.J. Radosevic-Jelic, T. Josifovski, M. Micev, I. Popov,